期刊
ONCOTARGET
卷 7, 期 1, 页码 622-637出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.5807
关键词
colorectal cancer; lncRNA; ZFAS1; CDK1
资金
- project 'Employment of Best Young Scientists for International Cooperation Empowerment' [CZ.1.07/2.3.00/30.0037]
- European Social Fund
- state budget of the Czech Republic
- project CEITEC [CZ.1.05./1.1.00/02.0068]
- MZ CR - RVO (MOU) [00209805]
- project BBMRI CZ [LM2010004]
- projects IGA MZCR [NT13549-4/2012, NT13860-4/2012]
- Deutsche Forschungsgemeinschaft [SFB960]
We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue (P < 0.0001). By use of CRC cell lines (HCT116+/+, HCT116-/- and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFAS1 silencing, but cyclin B1 was decreased in both cell lines. We observed significant increase in p53 levels and PARP cleavage in CRC cell lines after ZFAS1 silencing indicating increase in apoptosis. Our data suggest that ZFAS1 may function as oncogene in CRC by two main actions: (i) via destabilization of p53 and through (ii) interaction with CDK1/cyclin B1 complex leading to cell cycle progression and inhibition of apoptosis. However, molecular mechanisms behind these interactions have to be further clarified.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据